Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
14 hours ago
New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney disease